BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 22487976)

  • 21. The benefit of bone-seeking radiopharmaceuticals in the treatment of metastatic bone pain.
    Liepe K; Runge R; Kotzerke J
    J Cancer Res Clin Oncol; 2005 Jan; 131(1):60-6. PubMed ID: 15449184
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bone-seeking radionuclides for therapy.
    Lewington VJ
    J Nucl Med; 2005 Jan; 46 Suppl 1():38S-47S. PubMed ID: 15653650
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radiometabolic treatment of bone-metastasizing cancer: from 186rhenium to 223radium.
    Rubini G; Nicoletti A; Rubini D; Asabella AN
    Cancer Biother Radiopharm; 2014 Feb; 29(1):1-11. PubMed ID: 24180669
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The palliative management of skeletal metastases in prostate cancer: use of bone-seeking radionuclides and bisphosphonates.
    Hamdy NA; Papapoulos SE
    Semin Nucl Med; 2001 Jan; 31(1):62-8. PubMed ID: 11200206
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Teletherapy and radiopharmaceutical therapy of painful bone metastases.
    Silberstein EB
    Semin Nucl Med; 2005 Apr; 35(2):152-8. PubMed ID: 15765378
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparative study of 188Re-HEDP, 186Re-HEDP, 153Sm-EDTMP and 89Sr in the treatment of painful skeletal metastases.
    Liepe K; Kotzerke J
    Nucl Med Commun; 2007 Aug; 28(8):623-30. PubMed ID: 17625384
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Samarium-153 ethylenediamine tetramethylene phosphonate therapy for bone pain palliation in skeletal metastases.
    Tripathi M; Singhal T; Chandrasekhar N; Kumar P; Bal C; Jhulka PK; Bandopadhyaya G; Malhotra A
    Indian J Cancer; 2006; 43(2):86-92. PubMed ID: 16790946
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radiopharmaceuticals for the palliation of painful bone metastases.
    Reisfield GM; Silberstein EB; Wilson GR
    Am J Hosp Palliat Care; 2005; 22(1):41-6. PubMed ID: 15736606
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of ¹⁸F-fluoride PET-CT on implementing early treatment of painful bone metastases with Sm-153 EDTMP.
    Storto G; Gallicchio R; Pellegrino T; Nardelli A; De Luca S; Capacchione D; Sirignano C; Pace L
    Nucl Med Biol; 2013 May; 40(4):518-23. PubMed ID: 23522973
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Radionuclide therapy for the treatment of skeletal metastases of urological malignancies: a forgotten therapy?].
    Badawi JK
    Dtsch Med Wochenschr; 2012 Aug; 137(33):1645-9. PubMed ID: 22875692
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 153Sm-EDTMP for bone pain palliation in skeletal metastases.
    Maini CL; Bergomi S; Romano L; Sciuto R
    Eur J Nucl Med Mol Imaging; 2004 Jun; 31 Suppl 1():S171-8. PubMed ID: 15127241
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Radioprotection and environmental pollution by the use of the radionuclides 89Sr, 186Re, and 153Sm for pain palliation in metastatic bone diseases. Related calculations].
    Sbonias E
    Hell J Nucl Med; 2005; 8(2):68-73. PubMed ID: 16142246
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeted Radionuclide Therapy of Painful Bone Metastases: Past Developments, Current Status, Recent Advances and Future Directions.
    Dash A; Das T; Knapp FFR
    Curr Med Chem; 2020; 27(19):3187-3249. PubMed ID: 30714520
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A new look at radionuclides therapy in metastatic disease of bone (review and prospects).
    Kim SI; Chen DC; Muggia FM
    Anticancer Res; 1988; 8(4):681-4. PubMed ID: 2460020
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeted "bone-seeking" radiopharmaceuticals for palliative treatment of bone metastases: a systematic review and meta-analysis.
    D'angelo G; Sciuto R; Salvatori M; Sperduti I; Mantini G; Maini CL; Mariani G
    Q J Nucl Med Mol Imaging; 2012 Dec; 56(6):538-43. PubMed ID: 23358407
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Radionuclide treatment of painful bone metastases in patients with breast cancer: a systematic review.
    Christensen MH; Petersen LJ
    Cancer Treat Rev; 2012 Apr; 38(2):164-71. PubMed ID: 21683530
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeted radiotherapy of bone malignancies.
    Jansen DR; Krijger GC; Kolar ZI; Zonnenberg BA; Zeevaart JR
    Curr Drug Discov Technol; 2010 Dec; 7(4):233-46. PubMed ID: 21034411
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radioisotopic treatment of bone pain from metastatic prostate cancer.
    Sartor O
    Curr Oncol Rep; 2003 May; 5(3):258-62. PubMed ID: 12667425
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radiopharmaceuticals for bone lesions. Imaging and therapy in clinical practice.
    Pauwels EK; Stokkel MP
    Q J Nucl Med; 2001 Mar; 45(1):18-26. PubMed ID: 11456371
    [TBL] [Abstract][Full Text] [Related]  

  • 40. EANM guidelines for radionuclide therapy of bone metastases with beta-emitting radionuclides.
    Handkiewicz-Junak D; Poeppel TD; Bodei L; Aktolun C; Ezziddin S; Giammarile F; Delgado-Bolton RC; Gabriel M
    Eur J Nucl Med Mol Imaging; 2018 May; 45(5):846-859. PubMed ID: 29453701
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.